Home › Prostate Cancer › California › Mountain View
Prostate Cancer clinical trials in Mountain View, CA
15 studies for Prostate Cancer are looking for participants at sites in and around Mountain View (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Recruiting
- USNC, Mountain View
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RecruitingPhase 1
- Stanford University Medical Center, Stanford · 5 mi away
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
RecruitingPhase 3
- Stanford Cancer Center ( Site 0046), Palo Alto · 5 mi away
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
RecruitingPhase 1
- Stanford University, Palo Alto · 5 mi away
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
RecruitingPhase 3
- Stanford Cancer Center ( Site 0036), Palo Alto · 5 mi away
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 1
- Research Site, Palo Alto · 5 mi away
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
RecruitingPhase 3
- Stanford University Medical Center, Palo Alto · 5 mi away
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RecruitingPhase 3
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi away
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Stanford Cancer Institute, Stanford University, Palo Alto · 5 mi away
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
RecruitingPhase 2/3
- VA Palo Alto Health Care System, Palo Alto · 5 mi away
- Stanford University Medical Center, Palo Alto · 5 mi away
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
RecruitingPhase 3
- Stanford University Medical Center, Stanford · 5 mi away
Prostate Active Surveillance Study
RecruitingObservational study
- Stanford University, Stanford · 5 mi away
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
RecruitingPhase 1
- Stanford Cancer Center, Palo Alto · 5 mi away
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RecruitingPhase 3
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi away
- VA Palo Alto Health Care System, Palo Alto · 5 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Stanford · 5 mi away
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY101 studies
- Houston, TX73 studies
- Los Angeles, CA64 studies
- Boston, MA56 studies
- Seattle, WA45 studies
- St. Louis, MO45 studies
- Chicago, IL45 studies
- Baltimore, MD45 studies
- San Francisco, CA44 studies
- Philadelphia, PA41 studies
- Nashville, TN40 studies
- Washington, DC39 studies
Other studies in Mountain View
- Cancer (all types)38 studies
- Breast Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Metastatic Cancer24 studies
- Lung Cancer20 studies
- Acute Myeloid Leukemia19 studies
- Ovarian Cancer19 studies
- Autism Spectrum Disorder17 studies
- Acute Lymphoblastic Leukemia14 studies
- Heart Failure14 studies
- Autism13 studies
- Endometrial Cancer12 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.